← All claims

Longevity & Aging · Metabolic & Cardiometabolic

testosterone replacement therapy individualized target 400-700 improves lean mass strength and reduces fat mass in clinically low-T men

In plain terms: Does TRT actually build muscle and cut fat in men with genuinely low testosterone?

Strong support Longevity & Aging
RefutedContestedStrong support
consensus score 0.71

Yes — in properly diagnosed hypogonadal men, RCTs consistently show TRT increases lean mass and reduces fat mass, with modest-to-real strength gains.

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

7 support 0 contradict 0 tested null 3 mixed · 10 sources, 7 independent groups

The evidence (10)

SourceGradeStanceQualityFinding
Wang
2004 · J Clin Endocrinol Metab
RCT mixed moderate Long-term testosterone gel increased lean and decreased fat mass in hypogonadal men but without significant gains in muscle strength.
Bhasin
2023 · J Gerontol A Biol Sci Med Sci
RCT supports high Review of randomized trials concludes testosterone reliably increases lean mass, muscle strength and leg power, though not consistently walking speed.
Barnouin
2021 · J Clin Endocrinol Metab
RCT supports moderate In older obese hypogonadal men, adding TRT to intensive lifestyle intervention preserved/increased lean mass and improved body composition beyond lifestyle alone.
Santi
2021 · Cells
meta-analysis supports moderate Meta-analysis in HIV-infected men found androgen administration improved body composition, increasing lean mass.
Corona
2016 · Eur J Endocrinol
meta-analysis supports high Meta-analysis found testosterone supplementation consistently increased lean mass and reduced fat mass.
Page
2005 · J Clin Endocrinol Metab
RCT supports moderate 36-month RCT in older men with low testosterone found T increased lean mass, grip strength and physical performance vs placebo.
Kolind
2022 · Andrology
RCT mixed moderate RCT in men with chronic-pain opioid-induced low-T: TRT improved body composition (lean/fat) but muscle-function/strength gains were limited, showing composition responds more reliably than functional strength.
Otzel
2024 · Front Neurol
RCT supports low Placebo-controlled pilot: high-dose TRT plus finasteride after spinal-cord injury improved body composition and muscle/bone outcomes without prostate enlargement (small n, adjunct-drug design).
Szarpak
2026 · Aging Male
meta-analysis mixed moderate Review of TRT in older men: musculoskeletal benefits (lean mass, bone) are real but the benefit/harm balance and functional/fracture endpoints remain uncertain.
Magnussen
2017 · Andrology
RCT supports moderate 24-wk RCT in aging men with T2DM and low bioavailable-T: TRT raised total lean mass (+1.9 kg) and lean leg mass, cut fat mass (-1.3 kg), and improved isometric/dynamic knee-extensor strength vs placebo.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.